Literature DB >> 28738290

Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review.

Ali Mousavizadeh1, Ali Jabbari2, Mohammad Akrami3, Hassan Bardania4.   

Abstract

Cell targeting peptides (CTP) are small peptides which have high affinity and specificity to a cell or tissue targets. They are typically identified by using phage display and chemical synthetic peptide library methods. CTPs have attracted considerable attention as a new class of ligands to delivery specifically therapeutic and diagnostic agents, because of the fact they have several advantages including easy synthesis, smaller physical sizes, lower immunogenicity and cytotoxicity and their simple and better conjugation to nano-carriers and therapeutic or diagnostic agents compared to conventional antibodies. In this systematic review, we will focus on the basic concepts concerning the use of cell-targeting peptides (CTPs), following the approaches of selecting them from peptide libraries. We discuss several developed strategies for cell-specific delivery of different cargos by CTPs, which are designed for drug delivery and diagnostic applications.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell targeting peptides; Targeted diagnostic agents; Targeted nano-carriers; Targeted therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28738290     DOI: 10.1016/j.colsurfb.2017.07.012

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  17 in total

1.  Mass spectrometry enumeration of filamentous M13 bacteriophage.

Authors:  Tingting Wang; Ai Nguyen; Linwen Zhang; Illarion V Turko
Journal:  Anal Biochem       Date:  2019-07-02       Impact factor: 3.365

Review 2.  Peptide-Modified Biopolymers for Biomedical Applications.

Authors:  Jessica Hersh; David Broyles; José Manuel Condor Capcha; Emre Dikici; Lina A Shehadeh; Sylvia Daunert; Sapna Deo
Journal:  ACS Appl Bio Mater       Date:  2020-12-24

Review 3.  Harnessing molecular recognition for localized drug delivery.

Authors:  Renjie Liu; Ran Zuo; Gregory A Hudalla
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 15.470

4.  Specific Targeting of Recombinant Human Pancreatic Ribonuclease 1 using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells.

Authors:  Amir Maleksabet; Hossein Zarei Jaliani; Amir Asgari; Amin Ramezani; Nasrollah Erfani
Journal:  Iran J Med Sci       Date:  2021-07

Review 5.  Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.

Authors:  Emma M Hays; Wei Duan; Sarah Shigdar
Journal:  Int J Mol Sci       Date:  2017-11-30       Impact factor: 5.923

6.  Effect of multiple cyclic RGD peptides on tumor accumulation and intratumoral distribution of IRDye 700DX-conjugated polymers.

Authors:  Xuebo Dou; Takahiro Nomoto; Hiroyasu Takemoto; Makoto Matsui; Keishiro Tomoda; Nobuhiro Nishiyama
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

Review 7.  A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy.

Authors:  Min Woo Kim; Seung-Hae Kwon; Jung Hoon Choi; Aeju Lee
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

8.  RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect.

Authors:  Hassan Bardania; Seyed Abbas Shojaosadati; Farzad Kobarfard; Dina Morshedi; Farhang Aliakbari; Mohammad Taher Tahoori; Elahe Roshani
Journal:  Iran J Biotechnol       Date:  2019-04-20       Impact factor: 1.671

Review 9.  Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.

Authors:  Bethany Almeida; Okhil K Nag; Katherine E Rogers; James B Delehanty
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

10.  Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed α v β 3 Integrin Receptors in Non-Small-Cell Lung Cancer.

Authors:  Nazanin Pirooznia; Khosrou Abdi; Davood Beiki; Farshad Emami; Seyed Shahriar Arab; Omid Sabzevari; Zahra Pakdin-Parizi; Parham Geramifar
Journal:  Contrast Media Mol Imaging       Date:  2020-03-31       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.